(Q24339566)

English

Identification of a new P1 residue mutation (444Arg----Ser) in a dysfunctional C1 inhibitor protein contained in a type II hereditary angioedema plasma

scientific article

In more languages

Statements

scholarly article

0 references

Identification of a new P1 residue mutation (444Arg----Ser) in a dysfunctional C1 inhibitor protein contained in a type II hereditary angioedema plasma (English)

0 references

Serpin family G member 1

1 reference

GOA release 2020-03-11

blood circulation

1 reference

GOA release 2020-03-11

hereditary angioedema

1 reference

based on heuristic

inferred from title

author name string

K S Aulak

1

0 references

M Cicardi

2

0 references

R A Harrison

3

0 references

language of work or name

0 references

publication date

18 June 1990

0 references

0 references

266

0 references

1-2

0 references

13-6

0 references

Interaction of 125I-labelled complement subcomponents C-1r and C-1s with protease inhibitors in plasma

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2890%2981494-9

21 January 2018

Inactivation of factor XII active fragment in normal plasma. Predominant role of C-1-inhibitor

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2890%2981494-9

21 January 2018

Contribution of Plasma Protease Inhibitors to the Inactivation of Kallikrein in Plasma

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2890%2981494-9

21 January 2018

Inactivation of kallikrein in human plasma

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2890%2981494-9

21 January 2018

The inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the C'1r subcomponent of the first component of complement by serum C'1 esterase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2890%2981494-9

21 January 2018

A BIOCHEMICAL ABNORMALITY IN HEREDIATRY ANGIONEUROTIC EDEMA: ABSENCE OF SERUM INHIBITOR OF C' 1-ESTERASE.

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2890%2981494-9

21 January 2018

HEREDITARY ANGIONEUROTIC EDEMA: TWO GENETIC VARIANTS.

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2890%2981494-9

21 January 2018

Behavior in vivo of normal and dysfunctional C1 inhibitor in normal subjects and patients with hereditary angioneurotic edema.

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2890%2981494-9

21 January 2018

The covalent nature of the human antithrombin III--thrombin bond

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2890%2981494-9

21 January 2018

Alpha-1-antitrypsin-Pittsburgh. A potent inhibitor of human plasma factor XIa, kallikrein, and factor XIIf

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2890%2981494-9

21 January 2018

A simplified method for cyanogen bromide activation of agarose for affinity chromatography

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2890%2981494-9

21 January 2018

Dysfunctional C1-inhibitor(At), isolated from a type II hereditary-angio-oedema plasma, contains a P1 'reactive centre' (Arg444----His) mutation

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2890%2981494-9

21 January 2018

The structural basis for neutrophil inactivation of C1 inhibitor.

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2890%2981494-9

21 January 2018

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2890%2981494-9

21 January 2018

Type II hereditary angioneurotic edema that may result from a single nucleotide change in the codon for alanine-436 in the C1 inhibitor gene

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2890%2981494-9

21 January 2018

C1 inhibitor and hereditary angioneurotic edema

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2890%2981494-9

21 January 2018

Hereditary angioneurotic edema. II. Deficiency of inhibitor for serum globulin permeability factor and/or plasma kallikrein

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2890%2981494-9

21 January 2018

Altered specificities of genetically engineered alpha 1 antitrypsin variants

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2890%2981494-9

21 January 2018

Human C1 inhibitor: improved isolation and preliminary structural characterization

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2890%2981494-9

21 January 2018

Antithrombin III Glasgow: a variant with increased heparin affinity and reduced ability to inactivate thrombin, associated with familial thrombosis

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2890%2981494-9

21 January 2018

Cloning and expression of the cDNA for human antithrom, bin III

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2890%2981494-9

21 January 2018

Identifiers

10.1016/0014-5793(90)81494-9

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24339566&oldid=1641271940"